Tivantinib in combination with Carboplatin and Pemetrexed as first line treatment in patients with advanced non-squamous NSCLC or Malignant Pleural Mesothelioma: results of phase I trial

被引：0
|
作者：
Zucali, P. A. [1 ]
Simonelli, M. [1 ]
De Vincenzo, F. [1 ]
Fatuzzo, G. [1 ]
Bertossi, M. [1 ]
Perrino, M. [1 ]
Miggiano, C. [1 ]
Giordano, L. [1 ]
Bonifacio, C. [1 ]
Sposta, F. Mrakic [1 ]
Santoro, A. [1 ]
机构：
[1] Humanitas Clin & Res Ctr, Humanitas Canc Ctr, Milan, Italy
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
H18
引用
收藏
页码：78 / 78
页数：1
相关论文
共 50 条
  • [1] Phase I trial of tivantinib in combination with carboplatin and pemetrexed as first-line treatment in patients with advanced nonsquamous non small cell lung cancer or malignant pleural mesothelioma.
    Zucali, Paolo Andrea
    Simonelli, Matteo
    De Vincenzo, Fabio
    Fatuzzo, Giuseppe
    Bertossi, Monica
    Perrino, Matteo
    Miggiano, Chiara
    Giordano, Laura
    Bonifacio, Cristiana
    Sposta, Federica Mrakic
    Santoro, Armando
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] Phase Lib trial of tivantinib in combination with carboplatin and pernetrexed as first-line treatment in patients (pts) with advanced nonsquamous NSCLC or malignant pleural mesotheliorna (MPM).
    Zucali, Paolo A.
    Simonelli, Matteo
    De Vincenzo, Fabio
    Fatuzzo, Giuseppe
    Bertossl, Monica
    Suter, Matteo B.
    Perrino, Matteo
    Giordano, Laura
    Santoro, Armando
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] PEMETREXED IN COMBINATION WITH CARBOPLATIN IN THE TREATMENT OF PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA
    Pasquini, E.
    Papi, M.
    Drudi, F.
    Tamburini, E.
    Genestreti, G.
    Nicoletti, S.
    Arcangeli, V
    Nicolini, M.
    Fabbri, P.
    Santo, A.
    Gianni, L.
    Fantini, M.
    Ravaioli, A.
    ANNALS OF ONCOLOGY, 2009, 20
  • [4] Pemetrexed-Carboplatin Versus Paclitaxel (Weekly)-Carboplatin as First Line Chemotherapy in Advanced Non-Squamous NSCLC
    Malik, P.
    Yadav, A.
    Jain, D.
    Pathy, S.
    Mohan, A.
    Khurana, S.
    Kumar, S.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S354 - S355
  • [5] Randomized phase III trial of nivolumab in combination with carboplatin, paclitaxel, and bevacizumab as first-line treatment for patients with advanced or recurrent non-squamous NSCLC
    Lee, J-S.
    Sugawara, S.
    Kang, J. H.
    Kim, H. R.
    Inui, N.
    Hida, T.
    Lee, K. H.
    Yoshida, T.
    Tanaka, H.
    Yang, C. T.
    Nishio, M.
    Ohe, Y.
    Tamura, T.
    Yamamoto, N.
    Yu, C-J.
    Akamatsu, H.
    Namba, Y.
    Sumiyoshi, N.
    Nakagawa, K.
    ANNALS OF ONCOLOGY, 2020, 31 : S1184 - S1185
  • [6] Carboplatin Plus Pemetrexed as First-line Treatment of Patients With Malignant Pleural Mesothelioma: A Phase II Study
    Katirtzoglou, Nikolaos
    Gkiozos, Ioannis
    Makrilia, Nektaria
    Tsaroucha, Emilia
    Rapti, Aggeliki
    Stratakos, Grigorios
    Fountzilas, Georgios
    Syrigos, Konstantinos N.
    CLINICAL LUNG CANCER, 2010, 11 (01) : 30 - 35
  • [7] PEMETREXED AND CARBOPLATIN VERSUS DOCETAXEL AND CARBOPLATIN AS FIRST-LINE TREATMENT FOR PATIENTS WITH ADVANCED, NON-SQUAMOUS, NON-SMALL CELL LUNG CANCER (NSCLC)
    Ganju, Vinod
    Pereira, Jose
    Kim, Joo-Hang
    Magallanes, Manuel
    Lee, Dae-Ho
    Wang, Jie
    Martinez, Luis
    Barraclough, Helen
    Van Kooten, Maximiliano
    Orlando, Mauro
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S417 - S418
  • [8] Updated Phase I Results of Carboplatin, Pemetrexed and Exemestane in Postmenopausal Women with Metastatic Non-Squamous NSCLC
    Young, P.
    Marquez, D.
    Noor, Z.
    Callahan, R.
    Jones, B.
    Wong, D.
    Goldman, J. W.
    Applebaum, S.
    Rausch, R.
    Yanes, C.
    Bueno, S.
    Garban, N.
    Elashoff, D.
    Garon, E.
    Pietras, R.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S504 - S504
  • [9] A Phase II Study of Pemetrexed plus Carboplatin Followed by Maintenance Pemetrexed in Elderly Patients with Advanced Non-Squamous NSCLC
    Tamiya, Motohiro
    Tamiya, Akihiro
    Kaneda, Hiroyasu
    Nakagawa, Kazuhiko
    Goto, Koichi
    Yoh, Kiyotaka
    Okamoto, Hiroaki
    Shimokawa, Tsuneo
    Tanaka, Hiroshi
    Abe, Tetsuya
    Daga, Haruko
    Takeda, Koji
    Hirashima, Tomonori
    Atagi, Shinji
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S316 - S316
  • [10] PEMETREXED IN COMBINATION WITH CISPLATIN IN THE FIRST-LINE TREATMENT OF NON-SQUAMOUS NSCLC: CZECH EXPERIENCE WITH 233 PATIENTS
    Skrickova, Jana
    Bortlicek, Zdenek
    Hejduk, Karel
    Pesek, Milos
    Kolek, Vitezslav
    Koubkova, Leona
    Roubec, Jaromir
    Tomiskova, Marcela
    Satankova, Monika
    Povolna, Zdenka
    Havel, Libor
    Coupkova, Helena
    Salajka, Frantisek
    Hrnciarik, Michal
    Zemanova, Milada
    Sixtova, Dimka
    Cernovska, Marketa
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S864 - S864
12345